PT1527197E - Associação do polimorfismo v286a da edg5 com diabetes mellitus do tipo ii e trombose venosa/embolismo pulmonar e a sua utilização - Google Patents

Associação do polimorfismo v286a da edg5 com diabetes mellitus do tipo ii e trombose venosa/embolismo pulmonar e a sua utilização Download PDF

Info

Publication number
PT1527197E
PT1527197E PT03729923T PT03729923T PT1527197E PT 1527197 E PT1527197 E PT 1527197E PT 03729923 T PT03729923 T PT 03729923T PT 03729923 T PT03729923 T PT 03729923T PT 1527197 E PT1527197 E PT 1527197E
Authority
PT
Portugal
Prior art keywords
type
diabetes mellitus
pulmonary embolism
venous thrombosis
association
Prior art date
Application number
PT03729923T
Other languages
English (en)
Inventor
Detlef Kozian
Evi Kostenis
Karl-Ernst Siegler
Martina Jacobs
Jean-Francois Deleuze
Sylvain Ricard
Sandrine Mace
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of PT1527197E publication Critical patent/PT1527197E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT03729923T 2002-04-09 2003-04-07 Associação do polimorfismo v286a da edg5 com diabetes mellitus do tipo ii e trombose venosa/embolismo pulmonar e a sua utilização PT1527197E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02007879 2002-04-09

Publications (1)

Publication Number Publication Date
PT1527197E true PT1527197E (pt) 2008-09-22

Family

ID=28685845

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03729923T PT1527197E (pt) 2002-04-09 2003-04-07 Associação do polimorfismo v286a da edg5 com diabetes mellitus do tipo ii e trombose venosa/embolismo pulmonar e a sua utilização

Country Status (12)

Country Link
EP (1) EP1527197B1 (pt)
JP (2) JP4284194B2 (pt)
AT (1) ATE398684T1 (pt)
AU (1) AU2003240449A1 (pt)
CA (1) CA2481300A1 (pt)
CY (1) CY1108340T1 (pt)
DE (1) DE60321684D1 (pt)
DK (1) DK1527197T3 (pt)
ES (1) ES2307938T3 (pt)
PT (1) PT1527197E (pt)
SI (1) SI1527197T1 (pt)
WO (1) WO2003085130A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579516B1 (en) 1995-06-13 2003-06-17 Zahra Mansouri Methods of delivering materials into the skin, and compositions used therein
JP5904501B2 (ja) * 2010-09-02 2016-04-13 国立研究開発法人理化学研究所 ２型糖尿病の検出方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057126A (en) * 1997-12-24 2000-05-02 Allelix Biopharmaceuticals, Inc. Mammalian EDG-5 receptor homologs
EP1071708A4 (en) * 1998-04-23 2005-01-19 Smithkline Beecham Corp GENE OF THE EDG FAMILY, HUMAN H218

Also Published As

Publication number Publication date
JP2005522199A (ja) 2005-07-28
ES2307938T3 (es) 2008-12-01
SI1527197T1 (sl) 2008-10-31
CA2481300A1 (en) 2003-10-16
WO2003085130A1 (en) 2003-10-16
CY1108340T1 (el) 2014-02-12
AU2003240449A1 (en) 2003-10-20
DK1527197T3 (da) 2008-10-20
EP1527197B1 (en) 2008-06-18
DE60321684D1 (de) 2008-07-31
JP4284194B2 (ja) 2009-06-24
ATE398684T1 (de) 2008-07-15
EP1527197A1 (en) 2005-05-04
JP4956565B2 (ja) 2012-06-20
JP2009171971A (ja) 2009-08-06

Similar Documents

Publication Publication Date Title
DK1092155T3 (da) Fremgangsmåde til tidlig diagnose af carcinomer
AU3084802A (en) Inflammatory markers as tools in the detection and prevention of diabetes mellitus and as tools to aid in the selection of agents to be used for the prevention and treatment of diabetes
NZ520659A (en) Xylanase variants having altered sensitivity to xylanase inhibitors caused by mutations in the lid region
PL323183A1 (en) Method of determining glycoproteins
DK1336109T3 (da) Kit og fremgangsmåde til at påvise proteinet EMS-1
Kanawa et al. Inactivity of μ‐calpain throughout postmortem aging of meat
NO964022L (no) -2-antichymotrypsinanaloger med elastasehemmende aktivitet
CA2366523A1 (en) Method for analyzing the amount of intraabdominal adipose tissue
WO2003027149A1 (fr) Anticorps et utilisation de ce dernier
PT1527197E (pt) Associação do polimorfismo v286a da edg5 com diabetes mellitus do tipo ii e trombose venosa/embolismo pulmonar e a sua utilização
WO1999037782A3 (en) Frozen food product
EP1780215A4 (en) MORBUS CROHN ANTIBODY PEPPTH PEPTIDE AND REAGENT TO TEST MORBUS CROHN
WO2004017992A3 (en) Ptk7 protein involvement in carcinoma
SE0300586D0 (sv) Diagnosis of autism
EP1801232A4 (en) METHOD FOR SORTING TRANSMEMBRANE ENZYME INHIBITOR SUBSTANCE
EP2071338A3 (en) Human diabetes-mediating proteins
CA2175060A1 (en) Oxidation-Resistant Muteins of Beta-Galactosidase Fragments
ES2060202T5 (es) Composicion detergente enzimatica liquida.
DE60136573D1 (de) Gewebefixativzusammensetzung
Brock et al. Characterization of monoferric fragments obtained by tryptic cleavage of bovine transferrin
WO2004070389A8 (en) Assay for protein isoforms
EP1321473A4 (en) METHOD FOR PREVENTING FROZEN ACTIVITY OF PROTEIN INDUCED BY FREEZING, AND USE OF POLYPEPTIDE IN THE PRODUCTION OF PREVENTIVE AGENT AGAINST SUCH ACTIVITY
WO2002082092A3 (de) Bestimmung der wirksamen parathormon-aktivität in einer probe
WO2003031983A3 (de) Verfahren zum nachweis von aminosäuren
Flores et al. Hydrolysis of alanine oligopeptides by porcine muscle alanyl aminopeptidase